Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focus
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Nature
Nature Cell Biology
Nature Reviews Molecular Cell Biology
The EMBO Journal
Nature Reports Stem Cells
Nature Reports Avian Flu
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Structural Biology  8, 271 - 279 (2001)
doi:10.1038/85029

Structures of two natural product methyltransferases reveal the basis for substrate specificity in plant O-methyltransferases

Chloe Zubieta1, Xian-Zhi He2, Richard A. Dixon2 & Joseph P. Noel1

1 Structural Biology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA.

2 Plant Biology Division, Samuel Roberts Noble Foundation, P.O. Box 2180, Ardmore, Oklahoma 73402, USA.

Correspondence should be addressed to Joseph P. Noel noel@sbl.salk.edu
Chalcone O-methyltransferase (ChOMT) and isoflavone O-methyltransferase (IOMT) are S-adenosyl-l-methionine (SAM) dependent plant natural product methyltransferases involved in secondary metabolism in Medicago sativa (alfalfa). Here we report the crystal structure of ChOMT in complex with the product S-adenosyl-l-homocysteine and the substrate isoliquiritigenin (4,2',4'-trihydroxychalcone) refined to 1.8 Å as well as the crystal structure of IOMT in complex with the products S-adenosyl-l-homocysteine and isoformononetin (4'-hydroxy-7-methoxyisoflavone) refined to 1.4 Å. These two OMTs constitute the first plant methyltransferases to be structurally characterized and reveal a novel oligomerization domain and the molecular determinants for substrate selection. As such, this work provides a structural basis for understanding the substrate specificity of the diverse family of plant OMTs and facilitates the engineering of novel activities in this extensive class of natural product biosynthetic enzymes.
Methylation of oxygen (O-methylation), nitrogen (N-methylation) and carbon (C-methylation) is a universal process critical to all organisms. In plants, the O-methylation patterns of polyhydroxylated small molecules are crucial to determining final product distribution via multiple branched biosynthetic pathways using the same or similar intermediates and substrates. The secondary metabolic pathway of phenylpropanoid biosynthesis uses cinnamate and acetate units to construct a diverse set of hydroxylated, polycyclic aromatic compounds, which are used for regulatory, structural and functional purposes in plants, including protection against UV photodamage, pigmentation, fertilization, signaling, gene induction1, 2, antimicrobial defense3, 4, chemoattraction5 and structural support6. Site specific methylation of flavonoid and isoflavonoid derivatives modulates their in vivo activity by limiting the number of reactive hydroxyl groups, altering the solubility properties of the resulting products and ultimately determining whether a particular small molecule will interact with cellular receptors.

Plant small molecule O-methyltransferases (OMTs) use S-adenosyl-l-methionine (SAM) as a methyl source, yielding S-adenosyl-l-homocysteine (SAH) and the methyl ether derivatives as products. This family of enzymes must conserve SAM binding while affording a sufficient degree of active site diversity to bind and correctly position a variety of disparate small molecules. Substrate discrimination by these plant OMTs is considerable given that plants synthesize several thousand phenylpropanoid compounds often with multiple hydroxyl groups7.

Chalcone O-methyltransferase (ChOMT), found in Medicago sativa L (alfalfa), methylates the 2'-hydroxyl of isoliquiritigenin (4,2',4'-trihydroxychalcone), converting it to 4,4'-dihydroxy-2'-methoxychalcone (Fig. 1). This latter compound serves as a potent nodulation (nod) gene inducer of soil rhizobia8, 9. Among the diverse compounds released from alfalfa roots, 4,4'-dihydroxy-2'-methoxychalcone acts as the most efficient transcriptional activator of nod genes, activating nodABC through interaction with the transcriptional regulators nodD1 and nodD2 of Rhizobium meliloti8. Additionally, ChOMT-mediated methylation of isoliquiritigenin prevents the chalcone isomerase (CHI) catalyzed cyclization of isoliquiritigenin to the flavanone liquiritigenin (7,4'-dihydroxyflavanone)10. Subsequent reactions convert flavanones into a variety of structurally diverse natural products, including anthocyanins, flavonols, pterocarpans, flavones and isoflavones.

Figure 1. Minimal phenylpropanoid biosynthetic pathway in M. sativa L (alfalfa)48.
Figure 1 thumbnail

Carbon flow begins in primary metabolism with phenylalanine, which ultimately serves as the building block for a diverse class of plant secondary metabolites. The enzymes depicted are: PAL, phenylalanine-ammonia lyase; CA4H, cinnamic acid 4-hydroxylase; 4CL, 4-coumarate:coenzyme A ligase; CHS, chalcone synthase; CHR, chalcone reductase; ChOMT, 4,2',4'-trihydroxychalcone 2'-hydroxyl-O-methyltransferase; CHI, chalcone isomerase; IFS, isoflavone synthase; IOMT, isoflavone-O-methyltransferase (isoflavanone-O-methyltransferase); IFOH, isoflavone 2'-hydroxylase; IFR, isoflavone reductase; and PTS, pterocarpan synthase. The reaction depicted in the solid black box occurs in vitro and likely represents a cryptic activity of IOMT, which normally would methylate an isoflavanone intermediate. The depicted dehydration step can spontaneously occur in solution over time or is catalyzed by a specific dehydratase enzyme. A-rings are derived from the head-to-tail condensation of malonyl-CoA derived acetyl groups and the B-rings are derived from the p-coumaryl moiety.



Full FigureFull Figure and legend (43K)
Isoflavone O-methyltransferase (IOMT) is essential for the biosynthesis of medicarpin, the major phytoalexin of alfalfa11. In vivo studies demonstrate that IOMT is necessary for the formation of formononetin. In vitro assays using daidzein as substrate and in vivo studies conducted in the absence of fungal elicitation of IOMT-overexpressing plants yield the compound isoformononetin12. This compound is rarely found in plants and has no known biological role in plant physiology. However, when elicited with CuCl2 or infection with Phoma medicaginis, IOMT-overexpressing plants accumulate the 4'-O-methylated isoflavonoid formononetin and the downstream phytoalexin derived from it, medicarpin (Fig. 1).

Here we report the X-ray crystal structures of ChOMT (Table 1) and IOMT (Table 2), two SAM dependent OMTs from M. sativa L. ChOMT and IOMT are 40 kDa proteins and exist as homodimers in solution. These methyltransferases possess SAM binding domains that align structurally with characterized viral13, bacterial14, 15, 16, 17, 18, 19, 20, archaebacterial21 and mammalian22, 23, 24 OMTs. The fold of the catalytic SAM binding domain is conserved throughout all classes of SAM-dependent methyltransferases25, 26, 27. Unique features of plant O-methyltransferases include the presence of a second domain involved in dimerization and the contribution of the dimer interface to the substrate binding site. The structures presented here in complex with substrates and products reveal a characteristic mechanism for methyl transfer by plant OMTs. Furthermore, these studies provide the first structural understanding of substrate discrimination displayed by the large family of plant OMTs.

Table 1. Crystallographic data, phasing and refinement information for ChOMT
Table 1 thumbnail

Full TableFull Table
Table 2. Crystallographic data, phasing and refinement information for IOMT
Table 2 thumbnail

Full TableFull Table
Overall structures of ChOMT and IOMT
Recombinant proteins were expressed in Escherichia coli as N-terminal polyhistidine-tagged proteins and purified by Ni+2 affinity chromatography and gel filtration. ChOMT and IOMT possessed specific activities comparable to published values9, 11. Both ChOMT and IOMT were crystallized from polyethylene glycol (PEG) solutions in the presence of a two-fold molar excess of SAM or SAH. Structures of ChOMT and IOMT were determined with selenomethionine (SeMet) substituted proteins using multiwavelength anomalous dispersion (MAD) phasing. Additional structures of substrate and product complexes were determined using difference Fourier analysis based on the SeMet derived structures (Fig. 2ac).

Figure 2. Architecture of the ChOMT and IOMT monomers.
Figure 2 thumbnail

a, Calpha traces of the backbones of the ChOMT and IOMT monomers. Every 20th Calpha atom is numbered and the N-termini and C-termini are labeled. The disordered loop in ChOMT between residues 160 and 173 is shown as a dashed coil. b, Stereo view of the final SIGMAA weighted 2|Fo - Fc| electron density map of the ChOMT active site encompassing the bound SAH and isoliquiritigenin (two conformations shown) molecules. Putative hydrogen bonds are shown as dashed green cylinders. Single letter amino acid code is used. The map is contoured at 1.5 sigma. c, Stereo view of the final SIGMAA weighted 2|Fo - Fc| electron density map of the IOMT active site encompassing the bound SAH and isoformononetin molecules. The map is contoured at 1.5 sigma.



Full FigureFull Figure and legend (304K)
ChOMT (Fig. 3a,b) and IOMT (Fig. 3c,d) exhibit a common tertiary structure consisting of a large C-terminal catalytic domain responsible for SAM binding and substrate methylation and a smaller N-terminal domain involved in dimerization and formation of the back wall of the substrate binding site. Due to this conservation of fold, the root mean square (r.m.s.) deviation for alignment of the catalytic domains is 1.4 Å, while both the catalytic and dimerization domains align with an r.m.s. deviation of 1.8 Å for all backbone atoms. The catalytic domain contains a core alpha/beta Rossmann fold common to nucleotide binding proteins28. Structural alignments with representative DNA and small molecule methyltransferases illustrate the presence of a conserved fold involved in SAM/SAH binding (Fig. 4a). Unlike most structurally characterized methyltransferases, which are monomeric, ChOMT and IOMT form homologous homodimers in their respective crystalline lattices. The monomers in both cases are related by a crystallographic two-fold axis. While ChOMT and IOMT were originally characterized as monomers, the recombinant proteins exhibit no monomer formation in solution. Dimerization appears to be critical for activity and most likely occurs in vivo as well as in vitro. The presence of a dimerization interface appears to be common to plant OMTs and intimately contributes to substrate binding.

Figure 3. Architecture of the ChOMT and IOMT dimers and active sites.
Figure 3 thumbnail

a, Ribbon and molecular surface representation of the ChOMT homodimer. Monomer A is rose, monomer B is green, and the bound SAH and isoliquiritigenin molecules are shown as half-colored bonds. b, Close-up stereo view of the substrate binding site highlighting some of the hydrogen bonding and van der Waals interactions with SAH. The view is shown in the same orientation as in (a). c, Ribbon and molecular surface representation of the IOMT homodimer. Monomer A is blue, monomer B is gold and the bound SAH and isoformononetin molecules are shown as half-colored bonds. d, Close-up stereo view of the substrate binding site highlighting some of the hydrogen bonding and van der Waals interactions with SAH. The ribbon diagrams were produced with MOLSCRIPT49 and the surface diagrams with GRASP50. Both were rendered with POV-Ray51. Some side chains have been omitted for clarity.



Full FigureFull Figure and legend (357K)
Figure 4. Structural and sequence comparisons of representative OMTs.
Figure 4 thumbnail

a, Structural comparison of IOMT, HhaI DNA C-methyltransferase (M.HhaI) and catechol O-methyltransferase ('COMT'). SAH, isoformononetin (IOMT), SAM (M.HhaI), SAM and dinitrocatechol (COMT) are shown as stick models. The conserved SAM/SAH binding domains are highlighted in gold and the nonconserved regions in blue. The reactions catalyzed by IOMT, M.HhaI and 'COMT' are illustrated with the transferred methyl group highlighted in blue. 'COMT' differs from the plant OMT called COMT, which stands for caffeic acid O-methyltransferase. b, Sequence alignment of nine representative plant O-methyltransferases. Primary (GenBank protein database) and secondary structure of IOMT from M. sativa (alfalfa; AAC49927) and ChOMT from M. sativa (alfalfa; AAB48059) and sequence alignment of caffeic acid OMT from M. sativa (alfalfa; AAB46623), scoulerine OMT from Coptis japonica (goldenthread; BAA06192), isoeugenol OMT from Clarkia breweri (fairy fans; AAC01533), hydroxymaackiain OMT from Pisum sativa (pea; AAC49856), diphenol OMT from Capsicum annum (hot pepper; AAC17455), catechol OMT from Nicotiana tabacum (tobacco; CAA52461), and flavonoid OMT from Hordeum vulgare (barley; CAA54616). alpha-Helices of IOMT are depicted as blue cylinders and beta-strands as blue arrows. alpha-Helices of ChOMT are depicted as rose cylinders and beta-strands as rose arrows. The numbering of each protein is in parentheses, with every 10th position dotted. Residues involved in SAM/SAH binding (pink), substrate binding (blue), substrate binding in trans from the dyad related polypeptide (green), and catalysis (yellow) are highlighted.



Full FigureFull Figure and legend (132K)
In ChOMT, the extensive dimerization interface buries 8,990 Å2 of surface area, encompassing approx30% of the available surface area of the dimer (Fig. 3a). Met 29, Thr 32 and Thr 33 insert into the catalytic domain of the neighboring molecule, thus forming the back wall of the neighboring molecule's active site. The extent of the IOMT interface is comparable, with 8,597 Å2 of buried surface area at the interface, comprising approx30% of the available surface area of the dimer (Fig. 3c). Tyr 25, Phe 27 and Ile 28 form the back wall of the catalytic domain of the dyad related monomer.

SAM/SAH binding
The structures of ChOMT and IOMT in complex with SAH clearly delineate a conserved SAH/SAM binding motif (Fig. 3b,d). The catalytic domains of ChOMT and IOMT maintain homologous alpha/beta folds consisting of helices 9−13 and beta-strands 3−9 (Fig. 4b). In addition to conservation of the OMT tertiary structure, positional conservation of the amino acids involved in cofactor binding is evident from the crystal structures of ChOMT and IOMT as well as sequence alignments of plant OMTs (Fig. 4b). SAH binding within the active site pocket of ChOMT is mediated through a network of hydrogen bonds as well as van der Waals interactions (Fig. 3b). IOMT binds SAH through a similar set of interactions (Fig. 3d). The residues involved in hydrogen bonding and van der Waals interactions with SAM/SAH are spatially equivalent in both methyltransferases. The two structures of ChOMT and IOMT highlight the analogous orientation of the bound SAH as well as the common chemical features of the SAM/SAH binding motif.

Hydroxylated substrate binding
Because of the broad structural diversity of plant phenylpropanoid compounds, most plant OMTs possess highly selective substrate and positional specificity. Efficient substrate discrimination and binding is achieved in ChOMT and IOMT through shape selectivity dictated by van der Waals interactions, including a rich set of aromatic and aliphatic side chains, and by specific hydrogen bonding patterns. In ChOMT, the isoliquiritigenin substrate adopts two conformations within the active site via a approx180° rotation around the carbonyl carbon, resulting in two distinct binding modes for the B-ring of isoliquiritigenin (Fig. 3b). The position of the A-ring, which presents the 2'-hydroxyl group to SAM for methylation, is conserved in both conformers. The A-ring is bound by the thioether moieties of Met 189 and Met 329. Thr 332 and the 4'-hydroxyl moiety of the substrate are within hydrogen bonding distance, which secures the substrate within the active site and most likely ensures that the A-ring 2'-hydroxyl is firmly positioned for deprotonation followed by methylation by the putative catalytic base, His 278, and the methyl donor, SAM, respectively. The back wall of the active site consists of residues Met 29, Thr 32, and Thr 33 donated from the partner monomer (Fig. 5a).

Figure 5. ChOMT and IOMT active sites.
Figure 5 thumbnail

a, ChOMT−isoliquiritigenin complex. The ribbon diagram approximates the global orientation of the ChOMT dimer used for the close-up view of the complete chalcone binding site depicted in stereo. The black box highlights the region of ChOMT shown in stereo. Bonds are color coded by atom type with isoliquiritigenin carbon atoms in charcoal and protein carbon atoms in brown. Hydrogen bonds are depicted as dashed cylinders and water molecules as green spheres. Residues labeled with (B) are contributed by the symmetric polypeptide chain. b, IOMT−isoformononetin complex (top panel) and model of a putative IOMT−(2S,3S)-2,4',7-trihydroxyisoflavanone complex (bottom panel) generated by the superposition of the B-ring of isoformononetin and the A-ring of 2,4',7-trihydroxyisoflavanone. The ribbon diagram approximates the global orientation of the IOMT dimer used for the close-up view of the isoflavone-binding site depicted in stereo. The black box highlights the region of IOMT shown in stereo. Bonds are color coded by atom type with isoflavone and isoflavanone carbon atoms in charcoal and protein carbon atoms in brown. Hydrogen bonds are depicted as dashed cylinders.



Full FigureFull Figure and legend (68K)
The IOMT active site uses the same chemical features for substrate binding as ChOMT. Due to the lack of aqueous stability exhibited by the isoflavanone substrate 2,7,4'-trihydroxyisoflavanone, the isoflavone daidzein was substituted in crystallization experiments because IOMT exhibits considerable activity towards this compound. Cocrystallization of IOMT with SAM and daidzein resulted in the formation of a product complex consisting of SAH and isoformononetin (Fig. 3d). Met 168 and Met 311 constrain the A-ring and help position the 7-hydroxyl group for methylation. Given the high degree of conservation of both Met residues in plant OMTs, the stereochemical features of these interactions are most likely conserved throughout the plant OMT superfamily (Fig. 4b). Furthermore, this degree of amino acid conservation suggests that the interaction of the Met thioether group with hydroxylated phenyl groups plays a major energetic role in orienting the aromatic ring so that it presents a hydroxyl group to SAM and the OMT catalytic machinery.

Tyr 25, Phe 27 and Ile 28 of the dyad related monomer of IOMT form the back wall of the active site (Fig. 5b). While these residues are contributed from the symmetrically arranged monomer, they do not align sequentially with the equivalent residues in ChOMT. These contacts between the active site of one monomer and the side chains from the symmetrically arranged monomer have important consequences for substrate specificity. In studies of OMTs involved in berberine biosynthesis, for example, the high sequence conservation (93−99% identity) of four methyltransferases allowed the formation of non-native heterodimers. The different isoforms had different substrate specificity profiles and in some cases heterodimer formation allowed these OMTs to accept new substrates29. Clearly, plant OMTs modulate the choice between chemically similar substrates through variation in the dimer interface.

In the unperturbed medicarpin biosynthetic pathway, IOMT almost certainly never encounters daidzein and thus produces no isoformononetin in vivo. While IOMT will methylate daidzein, this compound is not the in vivo substrate of IOMT. The apparent disparate results concerning IOMT methylation of daidzein in vitro to form isoformononetin and the absence of this compound in plants strongly implicate an unstable intermediate, most likely the product of isoflavone synthase (IFS) as the true in vivo substrate of IOMT30. The putative product of the cytochrome P450 enzyme IFS31, 32, 33 and substrate for IOMT is 2,7,4'-trihydroxyisoflavanone, a reactive intermediate in isoflavone biosynthesis. Because isoflavanones are unstable in aqueous solution, the full identification and characterization of the IFS product is incomplete34, 35. However, overexpression of IOMT in transgenic alfalfa leads to the increased production of 4'-O-methylated isoflavonoids30. Alfalfa microsomes containing IOMT can convert 4',7-dihydroxyisoflavanone to the physiological product formononetin (C. Liu & R. Dixon, unpublished results), thus implicating the formation of an IFS/IOMT complex during medicarpin biosynthesis30.

To investigate the structural basis for the apparent physiological preference of IOMT for its putative in vivo substrate, 2,4',7-trihydroxyisoflavanone, the four possible stereoisomers of 2,4',7-trihydroxyisoflavanone were modeled in the IOMT active site. The resulting model suggests that the optimally binding isomer is (2S,3S)-2,4',7-trihydroxyisoflavanone (Fig. 5b). All four stereoisomers were modeled by superimposing the 4'-hydroxyl moiety of the isoflavanone onto the observed location of the 7-methoxy group of isoformononetin. The resulting substrate specificity is most likely conferred by hydrogen bonding interactions that dictate the positioning of the physiological substrate, 2,4',7-trihydroxyisoflavanone, near the reactive methyl group of SAM and the catalytic base, His 257. The additional hydroxyl group located at carbon 2 and the ether oxygen at position 1 of the C-ring form putative hydrogen bonds with the side chain carbonyl and side chain amide of Asn 310, respectively. In addition, the 2-hydroxyl moiety of the C-ring potentially forms an additional hydrogen bond with the side chain sulfhydryl group of Cys 313. In a chemically similar manner, the carbonyl oxygen at carbon 4 of the C-ring forms a putative hydrogen bond with Cys 117. All of these newly formed interactions are not seen in the isoformononetin complex and likely serve to specifically sequester the isoflavanone substrate (Fig. 5b).

The accretion of hydrogen bonding interactions and the preservation of aromatic and hydrophobic interactions around the bound isoflavanone suggests that IOMT might display an energetic preference for the isoflavanone intermediate rather than the dehydrated isoflavone daidzein. Regardless of the substrate preference displayed in vitro, in vivo conditions most likely only allow for the presence of the isoflavanone substrate. In addition, in vivo analysis suggests that IOMT and IFS form a complex upon induction of the defense response, which would provide for efficient channeling of the isoflavanone product of IFS to IOMT30.

Reaction mechanism
Based both upon the structures of ChOMT and IOMT and sequence alignments with the large family of plant OMTs, methylation most likely proceeds via base-assisted deprotonation of the hydroxyl group followed by a nucleophilic attack of the newly generated phenolate anion of the substrate on the reactive methyl group of SAM. In ChOMT, deprotonation of the 2'-hydroxyl group of the A-ring by His 278 sets up the subsequent attack by the hydroxyl anion on the methyl group of SAM. Because the sulfur of SAM is positively charged, the transmethylation process is easily facilitated by the deprotonation step. Glu 306 and Glu 337 bracket the catalytic His residue, and the Ndelta nitrogen of this His makes a hydrogen bonding interaction to the carboxylate group of Glu 337 (Fig. 2b). This interaction ensures the optimal orientation of the imidazole group for deprotonation of the 2'-hydroxyl of the isoliquiritigenin substrate by the Nalt epsilon nitrogen of His 278 (Fig. 5a). Mutation of His 278 to Leu, Ala, Gln, Lys or Asn completely eliminated methyltransferase activity, further implicating His 278 as an important catalytic residue (Fig. 6).

Figure 6. Thin layer chromatography assay of ChOMT and IOMT catalytic His mutants.
Figure 6 thumbnail

Lanes 1−6 of the left panel refer to wild type ChOMT, and the mutants H278L, H278A, H278Q, H278K, and H278N, respectively. 14C-methylated 4,4'-dihydroxy-2'-methoxychalcone is labeled (*). Lanes 1−6 of the right panel correspond to wild type IOMT, and the mutants H257L, H257I, H257Q, H257K, and H257D, respectively. 14C-methylated product 4'-hydroxy-7-methoxyisoflavone (isoformononetin) is labeled (**).



Full FigureFull Figure and legend (83K)
Catalysis in IOMT proceeds through a comparable mechanism, with His 257 serving as the base responsible for deprotonation of the 7-hydroxyl group on the A-ring of daidzein (Fig. 5b). Similarly to ChOMT, Asp 288 and Glu 318 sterically constrain His 257 and position its Ndelta nitrogen through a hydrogen bond with Glu 318. This same catalytic mechanism would be predicted for the putative physiological substrate 2,7,4'-trihydroxyisoflavanone. Mutation of His 257 to Leu, Ile, Gln or Asp eliminated the methyltransferase activity towards daidzein. Mutation of the active site His to Lys caused greatly diminished activity compared to the wild type enzyme (Fig. 6).

Other methyltransferases use similar SN2 reactions36 involving oxygen, nitrogen and carbon based nucleophiles. The addition of methyl groups to carbon, such as seen in the C5 methylation of cytosine, usually proceeds via initial attack of an active site Cys residue on C6, which generates a resonance stabilized carbanion at C5. Small molecule O-methylation reactions, such as in catechol O-methyltransferase, are facilitated by metal mediated deprotonation22. Glycine N-methyltransferase23 and PvuII DNA-(cytosine N4) methyltransferase20 are postulated to use a Glu residue to deprotonate the amino moiety, thus facilitating methyl transfer. The putative role of His as a catalytic base has only been seen in one other structurally characterized methyltransferase, PRMT3 (protein arginine N-methyltransferase). The role of His in ChOMT and IOMT is similar to that of the His in the reaction mechanism proposed for PRMT3, which uses a His-Asp proton relay system24.

Conclusion
Plant small molecule OMTs constitute a unique family of methyltransferases. Plants elegantly modulate the methyltransferase fold, which is conserved throughout all kingdoms, in order to gain remarkable specificity and diversity in substrate recognition. This exquisite selectivity occurs through reconfiguration of the active site surface via side chain variation around the substrate binding pocket. Added diversity in the active site topology is attained through modulation of the dimerization interface. While certain plant methyltransferases, such as caffeic acid O-methyltransferase (COMT) demonstrate greater substrate promiscuity by methylating caffeoyl and 5-hydroxy coniferyl alcohols, aldehydes and free acids, the core scaffolds of these substrates are conserved with the differences occurring at the propanoid tail of the molecules. The activity profiles of COMT against these substrates show a high degree of variability, suggesting a kinetic preference for substrates in vivo (K. Parvathi, L. Chen & R. Dixon, unpublished results). However, the majority of plant OMTs act on unique substrates and catalyze O-methylations at specific sites with little or no activity towards other constituent hydroxyl moieties or towards related compounds37, 38.

Many of the amino acids directly involved in substrate binding are sequentially conserved in ChOMT and IOMT. In the extensive family of plant OMTs, the size of these residues varies due to the need to accommodate different but chemically related substrates (Fig. 4b). Alterations in the amino acid composition not only sterically modify the active site, but also provide unique hydrogen bonding scaffolds that lead to diverse substrate specificities and different distributions of methylated products. Furthermore, the abundance of Met residues in the active site used to sequester aromatic moieties is an important feature of these plant natural product methyltransferases. This conserved Met motif may be a widespread element used by plant aromatic OMTs to encapsulate their hydrophobic- and aromatic-rich substrates. Additionally, the pre-organization of the active site allows for facile substrate acceptance and helps restrict active site promiscuity by selecting for a unique small molecule scaffold. Upon SAM binding, the active site appears to be pre-arranged for substrate binding, as shown by the low r.m.s. deviation of 0.4 Å for the structures with and without substrate/product bound.

Because methylation patterns in large part determine product outcome, subtle alterations in methyltransferase substrate selectivity have a profound impact on secondary metabolic activities in plant cells. These high resolution crystal structures in complex with substrates and products provide the first three-dimensional picture of a diverse family of plant natural product biosynthetic enzymes and serve as a structural foundation for understanding the stereochemical principles underlying plant O-methyltransferase activity and substrate selectivity.

Methods
Materials.
The pET-15b expression vector and E. coli strain BL21(DE3) were purchased from Novagen. Ni2+-NTA resin was purchased from Qiagen. Benzamidine Sepharose and Superdex 200 FPLC columns were obtained from Pharmacia. SeMet, thrombin, S-adenosyl-l-methionine and S-adenosyl-l-homocysteine were obtained from Sigma. All oligonucleotides were purchased from Operon, Inc. Adenosyl-l-methionine-S-(methyl-14C) was purchased from New England Nuclear (NEN). 4,2',4'-trihydroxychalcone and 4',7-dihydroxyisoflavone were acquired from Indofine.

Expression, purification and mutagenesis.
The alfalfa ChOMT gene (GenBank accession number L10211) and IOMT gene (GenBank accession number AF000976) were inserted into the E. coli expression vector pHIS839 (ChOMT) or pET-15b (IOMT). ChOMT and IOMT constructs were transformed into E. coli BL21(DE3). Transformed E. coli were grown at 37 °C in terrific broth (TB) containing 50 mug ml-1 kanamycin (ChOMT) or 100 mug ml-1 ampicillin (IOMT) until A600nm = 1.0. After induction with 0.5 mM isopropyl 1-thio-beta-galactopyranoside (IPTG), the cultures were grown for 6 h at 25 °C. Cells were pelleted, harvested, and resuspended in lysis buffer (50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 20 mM imidazole (pH 8.0), 20 mM beta-mercaptoethanol, 10% (v/v) glycerol and 1% (v/v) Tween-20). After sonication and centrifugation, the supernatant was passed over a Ni2+-NTA column, washed with 10 bed volumes of lysis buffer, 10 bed volumes of wash buffer (50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 20 mM imidazole (pH 8.0), 20 mM beta-mercaptoethanol and 10% (v/v) glycerol), then the His tagged protein was eluted with elution buffer (50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 250 mM imidazole (pH 8.0), 20 mM beta-mercaptoethanol, and 10% (v/v) glycerol). Incubation with thrombin during dialysis for 24 h at 4 °C against 25 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM dithiothreitol (DTT) removed the N-terminal His tag. Dialyzed protein was reloaded onto a Ni2+-NTA column to remove cleaved His tag followed by thrombin depletion using a benzamidine Sepharose column. Gel filtration on a Superdex 200 column equilibrated with 25 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM DTT resulted in homogenous and active ChOMT and IOMT. Fractions containing the protein of interest were pooled and concentrated to approx25 mg ml-1 and stored at -80 °C. SeMet substituted protein was obtained from E. coli grown in minimal media with appropriate amino acids and SeMet added40. Expression and purification steps were as above. All mutants were generated with the QuikChange (Stratagene) protocol. Automated nucleotide sequencing confirmed the fidelity of the PCR products (Salk Institute DNA sequencing facility). All mutants were expressed as described above.

Enzyme activity assays.
Mutant enzymes were purified by Ni+2 affinity chromatography, dialyzed against 25 mM HEPES (pH 7.5), 100 mM NaCl, 2 mM DTT, and concentrated to approx2 mg ml-1. Qualitative activity assays were performed using 20 mug of protein, 500 muM substrate (2',4,4'-trihydroxychalcone for ChOMT and 4',7-dihydroxyisoflavone for IOMT), and 500 muM adenosyl-l-methionine-S-(methyl-14C), in 50 mul of 250 mM HEPES (pH 7.5), 100 mM NaCl. Reactions were allowed to proceed for 2 h at room temperature after which time the reaction products were extracted into ethyl acetate and applied to a Whatman LK6D silica TLC plate. Chromatograms were developed in ethyl actetate:hexane (50:50, v/v). The products were visualized by autoradiography.

Crystallography.
Crystals of ChOMT and IOMT were grown by vapor diffusion in hanging drops containing a 1:1 mixture of protein and crystallization buffer (ChOMT, 12% (w/v) PEG 8000, 0.05 M HEPES (pH 7.5), 0.3 M ammonium acetate, 2 mM DTT at 4 °C ; IOMT, 17% (w/v) PEG 8000, 0.05 M TAPS (pH 8.25), 0.35 M lithium sulfate, 2 mM DTT, 15 °C). Crystals for both proteins grew in space group C2 with one molecule per asymmetric unit. Unit cell dimensions for ChOMT were a = 127.19 Å, b = 53.79 Å, c = 73.55 Å, beta = 125.55°. IOMT cell dimensions were a = 145.56 Å, b = 50.54 Å, c = 63.82 Å, beta = 106.69°. Diffraction data were collected from single crystals mounted in a cryoloop and flash frozen in a nitrogen stream at 105 K. All diffraction data were collected at the Stanford Synchrotron Radiation Facility, beamline 9-2 (IOMT data and ChOMT SeMet data) on a Quantum 4 CCD detector and beamline 7-1 (ChOMT−isoliquiritigenin complex) on a 30 cm MAR imaging plate. All images were indexed and scaled using DENZO41 and the reflections merged with SCALEPACK41. The ChOMT and IOMT structures were determined using multiple wavelength anomalous dispersion (MAD) phasing on the SeMet substituted protein. Initial heavy atom sites were found with SOLVE42. SHARP43 was used to refine the initial sites and to locate additional sites. MAD phases were improved with SOLOMON44. Subsequent complexes were solved by the difference Fourier method. All refinements were carried out using CNS45. During refinements, structure factors obtained from intensity data were used to generate SIGMAA weighted |2Fo - Fc| and |Fo - Fc| electron density maps with phases calculated from the structure of the in-progress model. Inspection of the electron density maps and model building was performed in O46. The quality of all models was assessed using the program PROCHECK47. For the ChOMT−isoliquiritigenin, complex 92.6%, 6.4%, 0.7%, and 0.3% of the residues were found in the most favored, the allowed, the generously allowed, and the disallowed regions of the Ramachandran plot, respectively, with a G factor of 0.39. For the IOMT−isoformononetin complex, 91%, 8%, and 1% of the residues were found in the most favored, the allowed, and the generously allowed regions of the Ramachandran plot, respectively, with a G factor of 0.30.

Coordinates.
Coordinates have been deposited in the Protein Data Bank (accession codes 1FPQ , 1FP1 , 1FPX , 1FP2 for the ChOMT−SAH, ChOMT−SAH−isoliquiritigenin, IOMT−SAH, and IOMT−SAH−isoformononetin complexes, respectively).

 Top
Received 21 August 2000; Accepted 22 January 2001

REFERENCES
  1. Hartwig, U.A., Maxwell, C.A., Joseph, C.M. & Phillips, D.A. Effects of alfalfa nod gene-inducing flavonoids on nodABC transcription in Rhizobium meliloti strains containing different nodD genes. J. Bacteriol. 172, 2769−2773 (1990). | PubMed | ISI | ChemPort |
  2. Peters, N.K., Frost, J.W. & Long, S.R. A plant flavone, luteolin, induces expression of Rhizobium meliloti genes. Science 233, 977−980 (1986). | PubMed | ISI | ChemPort |
  3. Smith, D.A. & Banks, S.W. Formation and biological properties of isoflavonoid phytoalexins. Prog. Clin. Biol. Res. 213, 113−124 (1986). | PubMed | ChemPort |
  4. Ingham, J.L. & Millar, R.L. Sativin: an induced isoflavan from the leaves of Medicago sativa L. Nature 242, 125−126 (1973). | ISI | ChemPort |
  5. Dobson, H.E.M. Floral volatiles in insect biology. In Insect-plant interactions. (ed., Bernays, E.) 47−81 (CRC Press, Boca Raton, Florida; 1993).
  6. Lewis, N.G., Davin, L.B. & Sarkanen, S. The nature and function of lignins. In Comprehensive natural products chemistry 3 (eds Barton, D. & Nakanishi, K.) (Elsevier Science Ltd., Amsterdam; 1999). | ChemPort |
  7. Barton, D. & Nakanishi, K. Comprehensive Natural Products Chemistry 1 (Elsevier Science Ltd., Amsterdam; 1999).
  8. Maxwell, C.A., Harrison, M.J. & Dixon, R.A. Molecular characterization and expression of alfalfa isoliquiritigenin 2'-O-methyltransferase, an enzyme specifically involved in the biosynthesis of an inducer of Rhizobium meliloti nodulation genes. Plant J. 4, 971−981 (1993). | Article | PubMed | ISI | ChemPort |
  9. Maxwell, C.A., Edwards, R. & Dixon, R.A. Identification, purification, and characterization of S-adenosyl-L-methionine: isoliquiritigenin 2'-O-methyltransferase from alfalfa (Medicago sativa L.). Arch. Biochem. Biophys. 293, 158−166 (1992). | Article | PubMed | ISI | ChemPort |
  10. Jez, J.M., Bowman, M.E., Dixon, R.A. & Noel, J.P. Structure and mechanism of the evolutionarily unique plant enzyme chalcone isomerase. Nature Struct. Biol. 7, 786−791 (2000). | Article | PubMed | ISI | ChemPort |
  11. He, X-Z. & Dixon, R.A. Affinity chromatography, substrate/product specificity, and amino acid sequence analysis of an isoflavone O-methyltransferase from alfalfa (Medicago sativa L.). Arch. Biochem. Biophys. 336, 121−129 (1996). | Article | PubMed | ISI | ChemPort |
  12. He, X-Z., Reddy, J.T. & Dixon, R.A. Stress response in alfalfa (Medicago sativa L). XXII. cDNA cloning and characterization of an elicitor-inducible isoflavone 7-O-methyltranferase. Plant Mol. Biol. 36, 43−54 (1998). | Article | PubMed | ISI | ChemPort |
  13. Hodel, A.E., Gershon, P.D., Shi, X. & Quiocho, F.A. The 1.85 Å structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends. Cell 85, 247−256 (1996). | Article | PubMed | ISI | ChemPort |
  14. Cheng, X., Kumar, S., Posfai, J., Pflugrath, J.W. & Roberts, R.J. Crystal structure of the HhaI DNA methyltranferase complexed with S-adenosyl-L-methionine. Cell 74, 299−307 (1993). | Article | PubMed | ISI | ChemPort |
  15. Schroeder, S.G. & Samudzi, C.T. Structural studies of EcoRII methylase: exploring similarities among methylases. Protein Eng. 10, 1385−1393 (1997). | Article | PubMed | ISI | ChemPort |
  16. Djordjevic, S. & Stock, A.M. Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine. Structure 5, 545−558 (1997). | Article | PubMed | ISI | ChemPort |
  17. Schluckebier, G., Zhong, P., Stewart, K.D., Kavanaugh, T.J. & Abad-Zapatero, C. The 2.2 Å structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism. J. Mol. Biol. 289, 277−291 (1999). | Article | PubMed | ISI | ChemPort |
  18. Tran, P.H., Korszun, Z.R., Cerritelli, S., Springhorn, S.S. & Lacks, S.A. Crystal structure of the DpnM DNA adenine methyltransferase from the DpnII restriction system of Streptococcus pneumoniae bound to S-adenosylmethionine. Structure 6, 1563−1575 (1998). | Article | PubMed | ISI | ChemPort |
  19. Schluckebier, G., Kozak, M., Bleimling, N., Weinhold, E. & Saenger, W. Differential binding of S-adenosylmethionine S-adenosylhomocysteine and sinefungin to the adenine-specific DNA methyltransferase M.TaqI. J. Mol. Biol. 265, 56−67 (1997). | Article | PubMed | ISI | ChemPort |
  20. Gong, W., O'Gara, M., Blumenthal, R.M. & Cheng, X. Structure of PvuII DNA-(cytosine N4) methyltransferase, an example of domain permutation and protein fold assignment. Nucleic Acids Res. 25, 2702−2715 (1997). | Article | PubMed | ISI | ChemPort |
  21. Hashimoto, H., Inoue, T., Nishioka, M., Fujiwara, S., Takagi, M., Imanaka, T. & Kai, Y. Hyperthermostable protein structure maintained by intra and inter-helix ion-pairs in archaeal O6-methylguanine-DNA methyltransferase. J. Mol. Biol. 292, 707−716 (1999). | Article | PubMed | ISI | ChemPort |
  22. Vidgren, J., Svensson, L. & Liljas, A. Crystal structure of catechol O-methyltransferase. Nature 368, 354−358 (1994). | Article | PubMed | ISI | ChemPort |
  23. Pattanayek, R., Newcomer, M.E. & Wagner, C. Crystal structure of apo-glycine N-methyltransferase (GNMT). Protein Sci. 7, 1326−1331 (1998). | PubMed | ISI | ChemPort |
  24. Zhang, X., Zhou, L. & Cheng, X. Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J. 19, 3509−3519 (2000). | Article | PubMed | ChemPort |
  25. Kagan, R.M. & Clarke, S. Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes. Arch. Biochem. Biophys. 310, 417−427 (1994). | Article | PubMed | ISI | ChemPort |
  26. O'Gara, M., McCloy, K., Malone, T. & Cheng, X. Structure-based alignment of three Ado-Met-dependent DNA methyltransferases. Gene 157, 135−138 (1995). | Article | PubMed | ChemPort |
  27. Schluckebier, G., O'Gara, M., Saenger, W. & Cheng, X. Universal catalytic domain structure of AdoMet-dependent methyltransferases. J. Mol. Biol. 247, 16−20 (1995). | Article | PubMed | ISI | ChemPort |
  28. Rossmann, M.G., Moras, D. & Olsen, K.W. Chemical and biological evolution of a nucleotide-binding protein. Nature 250, 194−199 (1974). | PubMed | ISI | ChemPort |
  29. Frick, S. & Kutchan, T.M. Molecular cloning and functional expression of O-methyltransferases common to isoquinoline alkaloid and phenylpropanoid biosynthesis. Plant J. 17, 329−339 (1999). | Article | PubMed | ISI | ChemPort |
  30. He, X-Z. & Dixon, R.A. Genetic manipulation of isoflavone 7-O-methyltransferase enhances the biosynthesis of 4'-O-methylated isoflavonoid phytoalexins and disease resistance in alfalfa. Plant Cell 12, 1689−1702 (2000). | Article | PubMed | ISI | ChemPort |
  31. Steele, C.L., Gijzen, M., Qutob, D. & Dixon, R.A. Molecular characterization of the enzyme catalyzing the aryl migration reaction of isoflavonoid biosynthesis. Arch. Biochem. Biophys. 367, 146−150 (1999). | Article | PubMed | ISI | ChemPort |
  32. Akashi, T., Aoki, T. & Ayabe, S. Cloning and functional expression of a cytochrome P450 cDNA encoding 2-hydroxyisoflavanone synthase involved in biosynthesis of the isoflavonoid skeleton in licorice. Plant Physiol. 121, 821−828 (1999). | Article | PubMed | ISI | ChemPort |
  33. Jung, W., Yu, O., Lau, S.M.C., O'Keefe, D.P., Odell, J., Fader, G. & McGonigle, B. Identification and expression of isoflavone synthase, the key enzyme for biosynthesis of isoflavones in legumes. Nature Biotechnol. 18, 208−212 (2000). | Article | PubMed | ISI | ChemPort |
  34. Hashim, M. F., Hakamatsuka, T., Ebizuka, Y. & Sankawa U. Reaction mechanism of oxidative rearrangement of flavanone in isoflavone biosynthesis. FEBS Lett. 271, 219−222 (1990). | Article | PubMed | ISI | ChemPort |
  35. Kochs, G. & Grisebach, H. Enzymatic synthesis of isoflavones. Eur. J. Biochem. 155, 311−318 (1986). | Article | PubMed | ISI | ChemPort |
  36. Walsh, C. Enzymatic reaction mechanisms. (W.H. Freeman and Company, San Francisco; 1979).
  37. Ibrahim, R.K., Bruneau, A. & Bantignies, B. Plant O-methyltransferases: molecular analysis, common signature and classification. Plant Mol. Biol. 36, 1−10 (1998). | Article | PubMed | ISI | ChemPort |
  38. Ibrahim, R.K. Plant O-methyltransferase signatures. Trends Plant Sci. 2, 249−250 (1997). | Article | ISI |
  39. Jez, J.M., Ferrer, J.L., Bowman, M.E., Dixon, R.A. & Noel, J.P. Dissection of malonyl-coenzyme A decarboxylation from polyketide formation in the reaction mechanism of a plant polyketide synthase. Biochemistry 39, 890−902 (2000). | Article | PubMed | ISI | ChemPort |
  40. Doublie, S. Preparation of selenomethionyl proteins for phase determination. Methods Enzymol. 276, 523−530 (1997). | Article | PubMed | ISI | ChemPort |
  41. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307−326 (1997). | Article | PubMed | ISI | ChemPort |
  42. Terwilliger, T.C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D 55, 849−861 (1999). | Article | PubMed | ISI |
  43. de la Fourtelle, E. & Bricogne, G. Maximum likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276, 472−494 (1997).
  44. Abrahams, J.P. & Leslie, A.G.W. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D 49, 148−157 (1996). | Article |
  45. Brunger, A.T. et al. Crystallography and NMR system: a new software suite for macromolecular structure dertermination. Acta Crystallogr. D 54, 905−921 (1998). | Article | PubMed | ISI |
  46. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. D 49, 148−157 (1993). | Article | PubMed |
  47. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thrornton, J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283−291 (1993). | Article | ISI | ChemPort |
  48. Dixon, R.A. & Paiva, N.L. Stress-induced phenylpropanoid metabolism. Plant Cell 7, 1085−1097 (1995). | Article | PubMed | ISI | ChemPort |
  49. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946−950 (1991). | Article | ISI |
  50. Nicholls, A., Charp, K. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281−296 (1991). | PubMed | ISI | ChemPort |
  51. Amundsen, S. et al. X-POV-Team POV-Ray: persistence of vision ray-tracer. http://www.povray.org (1997).
 Top
Acknowledgments
We acknowledge the assistance provided by members of the Noel group and the staff of beamlines 7-1 and 9-2 at the Stanford Synchrotron Radiation Facility. The SSRL Biotechnology Program is supported by the NIH, National Center for Research Resources, Biomedical Technology Program, and the DOE, Office of Biological and Environmental Research. This work was supported by funds from the Salk Institute and the National Science Foundation awarded to J.P.N. C.Z. was supported by funds from the NIH Molecular Biophysics Training Grant administered by the University of California, San Diego and funds from the Samuel Roberts Noble Foundation.

FULL TEXT
Previous
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Abstract
Methods
Figures & Tables
Acknowledgments
References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Structural & Molecular Biology
ISSN: 1545-9993
EISSN: 1545-9985
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2001 Nature Publishing Group | Privacy policy